COVID-19 massive surveillance testing
A collective effort to stop COVID-19 and future pandemics
We have mobilized in collaboration with SUNY Downstate Health Sciences University – University Hospital of Brooklyn in a commitment to help stop the spread of COVID-19 and help answer the many unknown questions about this deadly virus. While we research these unknowns, the near-term solution to mitigating the spread of the pandemic is: Massive Surveillance Testing and Contact Tracing.
We are working on accelerating and automating testing methods while decreasing costs by testing micro populations together as a unit. By performing massive surveillance screenings, we envision the creation of a pipeline to perform pooled population-based testing that will:
- quickly identify positive cases
- cut the cost of testing dramatically
- still pinpoint a susceptible group that would need to undergo individual testing
- allow for immediate containment measures to prevent a major breakout
- allow children to safely return to school and individuals to safely return to work and other activities

Saliva: an effective alternative
Non-invasive saliva-based specimen increases throughput


Mirimus received a total of 65 saliva samples within 3 days from patients who tested either positive (32) or negative (33) using nasopharyngeal swabs.
- 97% positivity rate of saliva compared to NP swabs (Samples were not collected on the same day, which may have contributed to a negative saliva sample)
- Saliva samples were spiked into Rutgers FDA-approved SDN1000 saliva home collection kit (Spectrum LLC) and sent to Rutgers laboratory for reference testing
- 100% PPV compared to Rutgers laboratory testing
- Yale and other researchers have also thoroughly compared saliva to nasal swabs for COVID-19

Quickly identify positive cases
Rapidly detect COVID-19 infection with Mirimus SalivaClear™
Test Population
in Pools of 24

Detect COVID-19 Hotspot
12 – 24 hours for resultsRetest Hotspot
in Pools of 2

Increase Resolution
4 – 6 hours for resultsPatient Order
for Individual Tests

Identify Infected Individual
~ 2 hours for resultsReduce costs with pooled screening
COVID-19 individual diagnostic testing is not scalable for surveillance
Detect individual infections in a population




= 96 Individual Tests

- Low throughput
- Delayed turnaround time
- Limited scale
- High cost per negative result
Mirimus COVID-19 Saliva Pool Testing is highly effective for surveillance
Monitor and detect infection hotspots in a population




= 4 Pool Tests

- High throughput
- Rapid turnaround time
- Highly scalable
- Low cost per negative result